Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGvHD, and tuberculosis.
115180 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115180002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 242, C동 8층, 성남시
- Website:
- http://www.qurient.com/
Description
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-17 00:00 |
감사보고서제출
|
Korean | 23.9 KB | ||
| 2022-03-16 00:00 |
[기재정정]주주총회소집공고
|
Korean | 181.5 KB | ||
| 2022-03-16 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 157.9 KB | ||
| 2022-03-14 00:00 |
주주총회소집결의
|
Korean | 11.4 KB | ||
| 2022-03-14 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.3 KB | ||
| 2022-03-14 00:00 |
주주총회소집공고
|
Korean | 164.5 KB | ||
| 2022-03-14 00:00 |
의결권대리행사권유참고서류
|
Korean | 141.0 KB | ||
| 2022-03-14 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.6 KB | ||
| 2022-02-16 00:00 |
투자판단관련주요경영사항(면역항암제 Q702와 Pembrolizumab(키투르다) 병용 임상1B/2상 시험계획 제출)
|
Korean | 10.1 KB | ||
| 2022-02-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.0 KB | ||
| 2022-02-11 00:00 |
투자판단관련주요경영사항(COVID-19 치료제 후보물질 텔라세벡(Telacebec) 임상 2상 시험 자진 중단 결정)
|
Korean | 7.9 KB | ||
| 2022-02-08 00:00 |
투자판단관련주요경영사항(항암치료제 Q901 미국 임상 1/2상 시험 계획(IND) 승인)
|
Korean | 9.9 KB | ||
| 2022-01-14 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 10.7 KB | ||
| 2022-01-06 00:00 |
투자판단관련주요경영사항(항암치료제 Q901 미국FDA 임상 1/2상 시험 계획(IND) 신청)
|
Korean | 9.2 KB | ||
| 2021-12-20 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 92.0 KB |
Automate Your Workflow. Get a real-time feed of all Qurient Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qurient Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qurient Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
